Revised forecast
Fiscal year ending December 2026 · Interim period (cumulative second-quarter consolidated period)Previous forecast published 14 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The Company reviewed the organizational structure of its Dispensing segment, established a specialized activity structure staffed by selected members from across the Company, and strengthened its sales activities. This resulted in the acquisition of implementation and installation projects for option software related to health and welfare administration. Meanwhile, sales of some hardware-related products fell below expectations due to the impact of supply chain disruptions and other factors.
| Item | Details |
|---|---|
| Net Sales | ¥10,273 million → ¥10,411 million（+1.3%） |
| Operating profit | ¥447 million → ¥879 million（+96.6%） |
| Ordinary income | ¥791 million → ¥1,285 million（+62.5%） |
| Profit attributable to owners of the parent | ¥344 million → ¥646 million（+87.8%） |
| Net income per share | 4.97 yen → 9.34 yen |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Interim period (cumulative second-quarter consolidated period) |
| Publication date of previous forecast | 14 May 2026 |
| Previous-period results | Previous fiscal year results — cumulative interim consolidated period: net sales of ¥12,149 million, operating income of ¥2,080 million, ordinary income of ¥2,400 million, interim net income attributable to owners of the parent of ¥1,603 million, and interim net income per share of ¥23.18 |
| Reason for the revision | The Company reviewed the organizational structure of its Dispensing segment, established a specialized activity structure staffed by selected members from across the Company, and strengthened its sales activities. This resulted in the acquisition of implementation and installation projects for option software related to health and welfare administration. Meanwhile, sales of some hardware-related products fell below expectations due to the impact of supply chain disruptions and other factors. |
| Dividend forecast revision | No change to either the interim or year-end dividend forecast (unchanged from the announcement made on 14 May 2026) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company reviewed the sales structure for its Dispensing segment and strengthened its sales activities, resulting in the acquisition of implementation and installation projects for option software related to health and welfare administration. Meanwhile, sales of some hardware-related products fell below expectations due to supply chain disruptions and other factors.